Masimo | MASI - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
Abbott USD 8.52B 1.01B 2025-12
Accuray USD 63.34M 5.93M 2025-09
Align Technology USD 1B 103.43M 2025-09
AngioDynamics USD 41.64M 14.26M 2025-09
Artivion USD 64.91M 8.52M 2025-12
AtriCure USD 167.43M 19.56M 2025-12
Avanos Medical USD 89.8M 19.3M 2025-12
Baxter International USD 1.97B 240M 2025-12
Becton, Dickinson and Co. USD 740M 99M 2025-12
Boston Scientific USD 1.96B 690M 2025-12
Dexcom USD 917.7M 918M 2025-12
Edwards Lifesciences USD 2.69B 587.2M 2025-09
General Electric Aerospace USD 12.39B 109M 2025-12
Globus Medical USD 526.16M 154.39M 2025-12
Haemonetics USD 363.37M 66.94M 2025-12
Inogen USD 106.48M 2.79M 2025-09
Insulet USD 716.1M 41.3M 2025-12
Integra LifeSciences USD 235.05M 2.86M 2025-12
Intuitive Surgical USD 9.03B 601.6M 2025-12
Masimo USD 312.3M 162.7M 2025-09
Medtronic USD 1.15B 135M 2025-12
Orthofix International USD 82.02M 19.16M 2025-12
Owens Minor USD 281.99M 249.15M 2025-12
ResMed USD 1.42B 33.22M 2025-12
Steris USD 423.7M 104.5M 2025-12
Stryker USD 4.01B 755M 2025-12
Tandem Diabetes Care USD 90.63M 1.31M 2025-12
Teleflex USD 354M 100.3M 2025-09
Thermo Fisher Scientific USD 9.85B 7.87B 2025-12
Zimmer Biomet Holdings USD 591.9M 700.8M 2025-12